Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

Clinical trial NCT05626478 · COMPLETED

Trial details

NCT number: NCT05626478
Sponsor: Nicole Fram M.D.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Corneal Edema Corneal Defect Anterior Chamber Inflammation Ocular Pain Corneal Staining Visual Outcome CME - Cystoid Macular Edema

Start date: 2023-06-01
Primary completion: 2025-02-05
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.